C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2011
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371858A2 Human-Murine chimeric antibodies against respiratory syncytial virus
10/05/2011	EP2371845A1 Plants having enhanced yield-related traits and a method for making the same
10/05/2011	EP2371841A1 Methods for enhancing stress tolerance in plants and compositions thereof
10/05/2011	EP2371838A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371837A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371836A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371835A1 Inhibition of syk kinase expression
10/05/2011	EP2371834A1 Stabilized immunomodulatory oligonucleotides
10/05/2011	EP2371396A1 Truncated fragments of alpha synuclein in lewy body disease
10/05/2011	EP2371392A1 Calicheamicin derivative-carrier conjugates
10/05/2011	EP2371387A2 HIV consensus sequence antigens and their use in vaccina
10/05/2011	EP2371380A1 MVA expressing modified hiv envelope, gag, and pol genes
10/05/2011	EP2370598A2 Classification of nucleic acid templates
10/05/2011	EP2370584A1 Use of micrornas to control virus helper nucleic acids
10/05/2011	EP2370583A1 Use of at(n) insertions in promoter elements for controlling the expression levels of coding sequences in plants
10/05/2011	EP2370582A2 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
10/05/2011	EP2370581A2 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
10/05/2011	EP2370580A2 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
10/05/2011	EP2370579A2 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
10/05/2011	EP2370578A1 RNA INTERFERENCE MEDIATED INHIBITION OF EPITHELIAL SODIUM CHANNEL (ENaC) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
10/05/2011	EP2370577A2 Usirna complexes
10/05/2011	EP2370576A1 Nucleic acid purification method
10/05/2011	EP2370575A1 Targeted integration into the zp15 locus
10/05/2011	EP2370573A1 Fungal endoglucanases, their production and use
10/05/2011	EP2370572A1 Fungal endoglucanases, their production and use
10/05/2011	EP2370570A2 Cellulase cel5h related reagents and their use in microorganisms
10/05/2011	EP2370567A1 Novel method for generation of rna virus
10/05/2011	EP2370566A1 Isogenic human cell lines comprising mutated cancer alleles and process using the cell lines
10/05/2011	EP2370563A1 Bioprocessing ligno-cellulose into ethanol with recombinant clostridium
10/05/2011	EP2370555A2 Production of tailored oils in heterotrophic microorganisms
10/05/2011	EP2370554A2 Manufacturing of tailored oils in recombinant heterotrophic microorganisms
10/05/2011	EP2370473A2 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
10/05/2011	EP2370472A1 Leptin and leptin analog conjugates and uses thereof
10/05/2011	EP2370471A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/05/2011	EP2370470A1 Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins
10/05/2011	EP2370469A2 Anti-rhd monoclonal antibodies
10/05/2011	EP2370457A2 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury
10/05/2011	EP2370456A1 Expression cassettes for seed-specific expression in plants
10/05/2011	EP2370455A2 Virus like particle compositions and methods of use
10/05/2011	EP2370454A1 Wdrpuh epitope peptides and vaccines containing the same
10/05/2011	EP2370109A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
10/05/2011	EP2370108A1 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
10/05/2011	EP2370107A2 Selective anticancer chimeric peptide
10/05/2011	EP2370092A1 Modulation of olfml-3 mediated angiogenesis
10/05/2011	EP2370091A2 Compositions and methods relating to mir-31
10/05/2011	EP2369910A1 Methods and compositions for the improvement of plant tolerance to environmental stresses
10/05/2011	EP2284261A8 Method for production of polyester copolymer using genetically modified microorganism
10/05/2011	EP2231860B1 Polypeptide derived from protein a and able to bind pdgf
10/05/2011	EP2039765B1 Method for determination of 1,5-anhydroglucitol, and reagent composition for determination of 1,5-anhydroglucitol
10/05/2011	EP1992219B1 Plant having improved growth ability and disease resistance and method for production thereof
10/05/2011	EP1971684B1 Chimaeric fusion protein with superior chaperone and folding activities
10/05/2011	EP1934353B1 IL-15R alpha sushi domains as a selective and potent enahncer of IL-15 action though IL-15Rbeta/gamma , in hyperagonist IL-15 Ralpha sushi -IL 15 fusion proteins .
10/05/2011	EP1923463B1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hla-a2-positive patient and pharmaceutical comprising the antigen
10/05/2011	EP1863921B1 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
10/05/2011	EP1853708B1 Molecular optoelectronic device and method of fabricating the same
10/05/2011	EP1848804B1 Anti-muc1 alpha beta antibodies
10/05/2011	EP1844077B1 Dr5 antibodies and uses thereof
10/05/2011	EP1841463B1 Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc
10/05/2011	EP1835983B1 Process for the separation of magnetic particle fractions through a semi-permeable membrane
10/05/2011	EP1828389B1 Sparc promoter mutations associated with drug resistance, and methods associated therewith
10/05/2011	EP1802757B1 Semi-soft c-class immunostimulatory oligonucleotides
10/05/2011	EP1784486B1 Nerve regeneration
10/05/2011	EP1766007B1 Non-recombinant saccharomyces strains that grow on xylose
10/05/2011	EP1749097B1 Replication competent viruses capable of silencing virus inhibitory factor expression
10/05/2011	EP1731610B1 Proteins imparting boron-tolerance and genes thereof
10/05/2011	EP1727903B1 Modified xylanases exhibiting improved expression
10/05/2011	EP1711604B1 Diabetogenic epitopes
10/05/2011	EP1697391B1 Use of a low-oxygen environment in plant transformation
10/05/2011	EP1678310B1 Axmi-010, a delta-endotoxin gene and methods for its use
10/05/2011	EP1660682B1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/05/2011	EP1653912B1 Vaccine immunotherapy for immune suppressed patients
10/05/2011	EP1652916B1 Process for producing rose with modified color
10/05/2011	EP1578943B1 Novel variant hypocrea jecorina cbh1 cellulases
10/05/2011	EP1549769B1 Gene expression profiling from ffpe samples
10/05/2011	EP1530639B1 Polypeptides comprising a modified human serum albumin secretion pre-sequence with improved secretion yield
10/05/2011	EP1529110B1 Methods of mixing large numbers of heterologous genes
10/05/2011	EP1495115B1 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
10/05/2011	EP1414976B1 Wheat plants having increased resistance to imidazolinone herbicides
10/05/2011	EP1412493B1 Methods and compositions relating to improved lentiviral vector production systems
10/05/2011	EP1395279B1 Use of neublastin polypeptides for treating neuropathic pain
10/05/2011	EP1377680B1 Diagnosis and treatment of breast cancer based upon scn5a
10/05/2011	EP1347833B1 Sample processing device and method
10/05/2011	EP1272208B1 Use of vegf 165 and homologues to treat neuron disorders
10/05/2011	EP1269187B8 Function homology screening
10/05/2011	EP1246920B1 Prevention of affections associated with porcine circovirus-2
10/05/2011	EP1137777B1 Novel compounds derived from neisseria meningitidis
10/05/2011	EP1105468B1 A NOVEL PLASTID-TARGETING NUCLEIC ACID SEQUENCE, A NOVEL $g(b)-AMYLASE SEQUENCE, A STIMULUS-RESPONSIVE PROMOTER AND USES THEREOF
10/05/2011	EP1037523B1 Genetically engineered duckweed
10/05/2011	EP1017835B1 Cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy
10/05/2011	EP0975762B1 Type-1 ribosome-inactivating protein
10/05/2011	EP0774007B1 Production of oligosaccharides in transgenic plants
10/05/2011	CN1950510B Glutamine-rich maize seed protein and promoter
10/05/2011	CN1946407B Methods and composition for treating tumors and metastatic disease
10/05/2011	CN1914317B Transformed saccharomyces cerevisiae and method for mass-production of LK8 protein using the same
10/05/2011	CN1886499B A gene encoding an enzyme for catalyzing biosynthesis of lignan, and use thereof
10/05/2011	CN1882683B Microbe capable of producing dipeptide and process for producing dipeptide with the microbe
10/05/2011	CN1748033B Method for modifying plant growth characteristics
10/05/2011	CN1639339B Fermentation process
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use

1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 4023